DeepCurrents Investment Group »

Halozyme Therapeutics shares owned by DeepCurrents Investment Group

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by DeepCurrents Investment Group from 13F filings

Historical chart of DeepCurrents Investment Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by DeepCurrents Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by DeepCurrents Investment Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $52M 45M 1.15

More positions owned by DeepCurrents Investment Group

At&t Put Option (T)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Sea Note 2.375%12/0 (Principal)
Nova Note 10/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Stride Note 1.125% 9/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Spotify Usa Note 3/1 (Principal)
Strategy Note 0.625% 9/1 (Principal)
Shift4 Pmts Note 12/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Cloudflare Note 8/1 (Principal)
Novocure Note 11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)

View all positions for DeepCurrents Investment Group

Top funds holding Halozyme Therapeutics

Steelhead Partners
Opti Capital Management
Linden Advisors
Millennium Management
MacKay Shields
DeepCurrents Investment Group
Tenor Capital Management
BlackRock
Lazard Asset Management
M&G
Calamos Advisors
Wellesley Investment Advisors
UBS O'Connor
Jpmorgan Chase & Co
State Street Corporation

View all funds holding Halozyme Therapeutics